Kubota Pharmaceutical Holdings Co., Ltd.
4596.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.84B
Close$
Share Statistics
| Market cap | $8.84 Billion |
|---|---|
| Enterprise Value | $7.27 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.59 |
| Beta | 1.82 |
| Outstanding Shares | 148,156,702 |
Return
| Return on Equity | -54.66% |
|---|---|
| Return on Assets | -49.31% |
| Return on Invested Capital | -67.26% |
Valuation & Multiples
| P/E Ratio | -7.72 |
|---|---|
| PEG | -10.11 |
| Price to Sales | - |
| Price to Book Ratio | 6.3 |
| Enterprise Value to Revenue | 447.38 |
| Enterprise Value to EBIT | -6.74 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kubota Pharmaceutical Holdings Co., Ltd.
8 employees
CEO: Ryo Kubota Kubota Pharmaceutical Holdings Co., Ltd., an international entity established in Tokyo, Japan, in 2002, focuses on the creation and advancement of a diverse range of pharmaceutical treatments and medical devices. A primary asset in their...